Restore your gut microbiome with expert FMT therapy at certified clinics globally
Restore healthy gut bacteria balance through scientifically-proven fecal microbiota transplantation
Exceptional success rates for C. difficile infections and promising results for IBD and IBS
Access to accredited FMT clinics with experienced gastroenterologists worldwide
Comprehensive donor screening protocols ensuring safety and treatment efficacy
Primary FDA-approved indication with 90%+ cure rates
Crohn's disease and ulcerative colitis treatment
Improving symptoms through microbiome modulation
Emerging therapy for immune system regulation
Small intestinal bacterial overgrowth management
Research into obesity and diabetes applications
FMT is a medical procedure that involves transferring stool from a healthy donor into the gastrointestinal tract of a patient to restore a healthy gut microbiome. It's primarily used to treat recurrent C. difficile infections and is being researched for other digestive and autoimmune conditions.
FMT has shown remarkable success rates of 85-95% for treating recurrent C. difficile infections that haven't responded to antibiotics. Many patients experience symptom relief within days of the procedure.
FMT can be delivered through several methods: colonoscopy (most common), upper endoscopy, enema, or oral capsules. Your gastroenterologist will recommend the best method based on your condition and medical history.
When performed in certified clinics with properly screened donors, FMT is generally safe. Donors undergo extensive testing for infectious diseases and other health conditions. Minor side effects may include temporary bloating, cramping, or changes in bowel habits. Serious complications are rare when proper protocols are followed.
Donors undergo rigorous screening including blood and stool tests for infectious diseases, parasites, and harmful bacteria. They're also evaluated for medical history, medications, travel history, and lifestyle factors. Less than 3% of potential donors pass all screening criteria.
While FDA-approved for recurrent C. difficile, FMT is being studied for inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and certain metabolic and neurological conditions. These uses are considered experimental and should only be pursued through clinical trials or specialized programs.
Costs vary by location and delivery method, typically ranging from $2,000 to $10,000. Insurance coverage is improving for C. difficile treatment, but coverage for other conditions varies. Contact your insurance provider and clinic for specific cost information.
Preparation typically includes stopping antibiotics 24-48 hours before the procedure, bowel preparation (for colonoscopy delivery), and fasting requirements. Your medical team will provide specific instructions based on your delivery method and health status.
Disclaimer: The information provided on this website is for educational purposes only and should not be considered medical advice. Always consult with healthcare professionals for medical concerns. FMT treatment should only be performed by qualified medical professionals in certified clinical settings.